Articles by Investor's Business Daily: Crypto News & Expert Market Analysis | BingX

Investor's Business Daily

Investor's Business Daily

Oscar Slips As LifeStance, HCA Climb On Earnings, Payment Hike

Oscar Health stock fell despite a Q3 earnings beat and raised guidance while LifeStance and HCA extended breakouts on earnings and payment news.

Investor's Business Daily

Arm Stock: Chip Designer Beats Fiscal Q2 Targets

Arm beat analyst estimates for its fiscal second quarter and with its guidance for the current period. But Arm stock fell.

Investor's Business Daily

CVS Health Is Breaking Up. Is The Blue Wave To Blame?

CVS Health stock dived after announcing it will break off its retail pharmacy business. Congress, under Democrats, may have forced the split.

Investor's Business Daily

HCA Healthcare, Centene, Oscar Ride Blue Wave to Buy Points

HCA and Oscar led gains. The market expects Medicaid cuts to be limited. It also expects ACA subsidies to be restored.

Investor's Business Daily

Datadog Stock: Datadog Earnings Top Views. Shares Plunge On Weak Sales Outlook.

Datadog stock tanked despite Q3 earnings that easily beat estimates. Q4 revenue guidance fell short and signaled flat sequential growth.

Investor's Business Daily

Pfizer CEO Cites $80 Billion in Deals; 'Real Test' Still Ahead

The CEO said $80 billion in deals had been struck. A portfolio manager said the real test was still ahead.

Investor's Business Daily

Anthropic IPO Filing Reveals Computing Bill Near $900 Billion

Ahead of the Anthropic IPO, the startup said revenue climbed more than 1,100% to $17 billion in the third quarter.

Investor's Business Daily

Tesla Robotaxi Adds This New City, Stock Continues Rally

Tesla's robotaxi service is now available in seven cities in Texas and Florida. Tesla stock rose about 2% on Monday.

Investor's Business Daily

Eli Lilly CFO On Acquisition Spree: 'We Are Taking Bets' On Future Revenue

Eli Lilly blew past sales expectations Thursday and hiked its outlook on the back of strong performance from Mounjaro and Zepbound.

Risk Warning

Cryptocurrencies and their derivatives are innovative financial products with great volatility and high investment risks.

Although BingX is committed to providing users with easy-to-use trading tools, trading itself is still a highly sophisticated field. Trading digital assets and their derivatives are subject to high market risk and price volatility and may result in partial or total loss of account funds. You must carefully consider and exercise clear judgment to evaluate your financial situation and the aforementioned risks before using BingX Services. You shall be responsible for all losses arising therefrom. If necessary, please consult relevant professionals to make informed decisions before investing. By accessing, downloading, using or clicking on "I agree" to accept any BingX Services provided by BingX, you agree that you have read, understood and accepted all of the terms and conditions stipulated in BingX Terms of Use as well as our Privacy Policy.

Trading by copying or replicating the trades of other traders involves a high level of risks, even when copying or replicating the top-performing traders. Past performance of a BingX community member is not a reliable indicator of his future performance. Content on BingX's trading platform is generated by members of its community and does not contain advice or recommendations by or on behalf of BingX.